KPNA2 and hepatocellular carcinoma: Furthermore, KPNA2 has been reported by three independent groups to be a positive marker for poor prognosis and early recurrence for HCC patients [13–15], showing that both overall survival and recurrence-free survival rates were significantly lower in patients with higher KPNA2 expression.